Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New West Genetics has successfully commercialized proprietary non-GMO industrial hemp seed varieties and hybrids. Their AMPLIFY™ hybrid trait has achieved certified seed status and demonstrated superior yields in multi-site trials across North America. The company continues to innovate with new traits focused on sustainability and adaptation to diverse climates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New West Genetics.